“IN SILICO SCREENING OF EFAVIRENZ AND EFAVIRENZ NICOTINAMIDE COCRYSTAL FOR ITS ACTIVITY AGAINST HIV AND SARS COV-2” (2024) Nirma University Journal of Pharmaceutical Sciences, 10(1), pp. 71–86. doi:10.5281/.